New Brunswick's chief medical officer of health Dr. Jennifer Russell announced on Thursday that the province is pausing the use of the AstraZeneca COVID-19 vaccine for first doses, but will be accepting 13,500 doses of AstraZeneca next week and will be using it for second doses.
During a news briefing Thursday afternoon, Russell said two additional cases of vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), the rare blood clotting disorder connected with AstraZeneca, have been confirmed in the province — for a total of four cases.
Russell says discussions are ongoing at the national level about mixing vaccine brands.
New Brunswick is reporting 16 new cases of COVID-19, one of which involves someone isolating outside of the province.
For more info, please go to https://globalnews.ca/news/7858845/nb-covid-19-update-may-13/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
During a news briefing Thursday afternoon, Russell said two additional cases of vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), the rare blood clotting disorder connected with AstraZeneca, have been confirmed in the province — for a total of four cases.
Russell says discussions are ongoing at the national level about mixing vaccine brands.
New Brunswick is reporting 16 new cases of COVID-19, one of which involves someone isolating outside of the province.
For more info, please go to https://globalnews.ca/news/7858845/nb-covid-19-update-may-13/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews
- Category
- U.S. & Canada
- Tags
- global news, NB, News Brunswick
Sign in or sign up to post comments.
Be the first to comment